Company / Operating Cash Flow per Share
Neurogene Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$4.75
FY2025
5-year range
-$4.75 / -$1.29
FY2021-FY2025
Trend
-18.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has declined for 3 consecutive years, from $-1.29 in FY2018 to $-4.75 in FY2025.
Based on SEC 10-K filings.
-4.75 in FY2025.
Declined from $-1.90 to $-4.75 over the past 6 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Neurogene Inc.'s operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 18.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.75 | -18.5% |
| FY2024 | -$4.01 | -111.1% |
| FY2019 | -$1.90 | -47.5% |
| FY2018 | -$1.29 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026